In addition to nutritional supplements, the partnership will focus on developing medical information and “supportive services” for healthcare professionals and their patients.
Pharmaceutical group Helsinn Group (Lugano, Switzerland) has made a minority investment in Thorne Research Inc., a manufacturer of nutritional supplements marketed through healthcare practitioners. The companies will develop dietary supplements to support the unique needs of cancer patients.
“We believe there is a clear need for high-quality, clinically specific nutrition products for conditions related to cancer,” stated Riccardo Braglia, CEO of Helsinn Group.
In addition to nutritional supplements, the partnership will focus on developing medical information and “supportive services” for healthcare professionals and their patients.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.